 Selective uptake toxic nucleoside resistant cancer uptake thymidine analogue nude mice human xenografts choriocarcinoma colonic cancer uptake intestinal tissues times tumours tissue gamma counting ratio hydroxyurea cytosine arabinoside inhibitors ribonucleotide reductase combination methotrexate thymidine synthesis radioactivity tissues hours tumour normal tissue ratios corresponding nuclear grain counts reliable indicator selective uptake DNA excess addition unlabelled IUdR regimen uptake large amounts approach tumour resistant cell level inhibitor DNA synthesis novo result prior exposure inhibitor uptake toxic analogue normal renewal tissues resistant cancer cells synthesis corresponding normal nucleosides inhibitors cancer cells resistant incorporation toxic tumour DNA convenient agent approach cytotoxic DNA clinical potential reverse role chemotherapy development toxic non-radioactive nucleoside analogues